Duopharma Biotech Bhd (7148) — Tangible Net Worth Ratio
Duopharma Biotech Bhd (7148) has a Tangible Net Worth Ratio of 95.3% as of March 2026. This metric is calculated by deducting intangible assets (RM35.87 Million) from net assets (RM757.35 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore how fast is Duopharma Biotech Bhd growing its equity to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Duopharma Biotech Bhd Tangible Net Worth Ratio (2006–2025)
This chart shows how Duopharma Biotech Bhd's Tangible Net Worth Ratio has changed across 20 annual periods from 2006 to 2025. As of March 2026, the ratio stands at 95.3%, reflecting net assets of RM757.35 Million with intangible assets of RM35.87 Million MYR. For live market cap and overall valuation, see 7148 market cap overview.
Annual Tangible Net Worth Ratio for Duopharma Biotech Bhd (2006–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Duopharma Biotech Bhd from 2006 to 2025, covering 20 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore reinvestment intensity of Duopharma Biotech Bhd to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (MYR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 95.1% | RM757.62 Million | RM36.88 Million | RM1.45 Billion | ▲ +1.5 pp |
| 2024 | 93.7% | RM709.15 Million | RM44.87 Million | RM1.38 Billion | ▼ -0.7 pp |
| 2023 | 94.4% | RM687.12 Million | RM38.80 Million | RM1.35 Billion | ▲ +1.1 pp |
| 2022 | 93.3% | RM655.22 Million | RM43.98 Million | RM1.22 Billion | ▼ -0.4 pp |
| 2021 | 93.7% | RM624.00 Million | RM39.52 Million | RM1.16 Billion | ▼ -0.9 pp |
| 2020 | 94.6% | RM643.82 Million | RM35.07 Million | RM1.06 Billion | ▼ -0.1 pp |
| 2019 | 94.7% | RM529.75 Million | RM28.11 Million | RM919.80 Million | ▼ -1.3 pp |
| 2018 | 96.0% | RM481.04 Million | RM19.40 Million | RM836.38 Million | ▼ -0.7 pp |
| 2017 | 96.6% | RM479.87 Million | RM16.23 Million | RM705.24 Million | ▼ -0.6 pp |
| 2016 | 97.2% | RM454.52 Million | RM12.73 Million | RM661.46 Million | ▼ -0.8 pp |
| 2015 | 98.0% | RM449.72 Million | RM8.81 Million | RM633.45 Million | ▼ -0.4 pp |
| 2014 | 98.4% | RM193.63 Million | RM3.06 Million | RM222.48 Million | ▼ -1.0 pp |
| 2013 | 99.4% | RM182.65 Million | RM1.06 Million | RM205.65 Million | ▼ -0.6 pp |
| 2012 | 100.0% | RM170.50 Million | RM0.00 | RM198.03 Million | ▲ +0.0 pp |
| 2011 | 100.0% | RM164.44 Million | RM0.00 | RM197.52 Million | ▲ +0.0 pp |
| 2010 | 100.0% | RM157.87 Million | RM0.00 | RM196.48 Million | ▲ +0.0 pp |
| 2009 | 100.0% | RM142.74 Million | RM0.00 | RM173.36 Million | ▲ +0.0 pp |
| 2008 | 100.0% | RM130.55 Million | RM0.00 | RM150.38 Million | ▲ +0.0 pp |
| 2007 | 100.0% | RM114.21 Million | RM0.00 | RM127.33 Million | ▲ +0.0 pp |
| 2006 | 100.0% | RM145.43 Million | RM0.00 | RM159.01 Million | — |